TESTRED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Testred, and when can generic versions of Testred launch?
Testred is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in TESTRED is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Testred
A generic version of TESTRED was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TESTRED?
- What are the global sales for TESTRED?
- What is Average Wholesale Price for TESTRED?
Summary for TESTRED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| DailyMed Link: | TESTRED at DailyMed |
US Patents and Regulatory Information for TESTRED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | TESTRED | methyltestosterone | CAPSULE;ORAL | 083976-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
